Hosted on MSN

FDA approves third over-the-counter opioid overdose nasal spray

The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved ...
MarketWatch

Amphastar Pharmaceuticals Gets FDA Approval for Over-The-Counter Nasal Spray for Opioid Overdose

Amphastar Pharmaceuticals got approval from the Food and Drug Administration for an over-the-counter nasal spray to treat opioid overdose. The FDA said Tuesday the approval of Amphastar's Rextovy aims ...
Healio

FDA approves Rextovy, a third nonprescription naloxone nasal spray for opioid overdoses

Please provide your email address to receive an email when new articles are posted on . Rextovy is the third over-the-counter naloxone nasal spray to be approved for opioid overdoses. Fatal drug ...
Medical Xpress

FDA approves another over-the-counter naloxone nasal spray

"Reducing opioid overdose deaths is a top priority for the FDA," Mike Davis M.D., Ph.D., from the FDA Center for Drug Evaluation and Research, said in a statement. "Today's approval of an additional ...
KGW8

The FDA approves an additional over-the-counter naloxone nasal spray to combat opioid overdoses

WASHINGTON — The U.S. Food and Drug Administration (FDA) announced Tuesday that it has approved Rextovy, a 4-milligram naloxone hydrochloride nasal spray, for over-the-counter sale, expanding access ...
Yahoo

FDA approves third over-the-counter opioid overdose nasal spray

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the ...